e-ISSN 2598-3849       print ISSN 2527-8878

Vol 3, No 1 (2018)

Efektivitas Biaya Strategi DOTS Program Tuberkulosis antara Puskesmas dan Rumah Sakit Swasta Kota Depok

Fikrotul Ulya, Hasbullah Thabrany

Abstract


Abstrak

Angka penemuan Tuberkulosis (TB) tahun 2016 adalah sebesar 77% di dunia, sebesar 46,5% di Asia Tenggara dan sekitar 32 - 33% di Indonesia. Di Kota Depok angka penemuan TB mencapai 58%. Sektor swasta menjangkau 18,7% kasus TB di Kota Depok meskipun baru 40% RS swasta yang terlibat. Penelitian ini bertujuan untuk mengetahui apakah penerapan strategi DOTS di Rumah Sakit swasta Kota Depok lebih menghemat biaya dibandingkan di Puskesmas. Penelitian dilakukan selama 6 bulan dengan kohort retrospektif di Puskesmas DOTS, RS DOTS dan RS Non DOTS menggunakan 36 sampel per kelompok. Penghitungan dari perspektif societal dengan microcosting berdasarkan tarif, harga pasar, serta nilai anggaran. Outputnya angka pengobatan lengkap (Success Rate). Hasil penelitian menunjukkan Success Rate di puskesmas paling tinggi yaitu 86,1%, RS DOTS sebesar 77.78 % dan Non DOTS 63.89 %. Penambahan biaya provider terutama tenaga pelaksana khusus di puskesmas dan RS DOTS meningkatkan success rate. Biaya societal di puskesmas 42% dari biaya di RS swasta. ACER (Average Cost Effectiveness Ratio) menunjukkan RS yang melaksanakan strategi DOTS lebih cost effective. Untuk menaikkan 1% angka kesuksesan pengobatan membutuhkan biaya Rp 10.084.572 dengan melakukan intervensi program DOTS ke RS Swasta. Uji t independen menyatakan bahwa terdapat perbedaan bermakna biaya societal pengobatan tuberkulosis antara puskesmas, RS DOTS, dan RS Non DOTS.

 

Abstract

Global TB notification rate at 2016 was 77% and 46.5% in Southeast Asia. Indonesia last 5 years still remain at 32-33% where Depok City reached 58%. In Depok City, private sector contributed 18.7% of the notified TB case in 2016 although only 40% of private hospitals were involved. The aims of this study is to determine cost-effectiveness of DOTS strategy implementation at private hospital and Public Health Centre (PHC). Comparative study carried out for six months with cohort retrospective between PHC, DOTS and non DOTS hospitals using 36 samples per group. The calculation of the societal perspective with micro costing based on tariffs, market prices and budget value. Output is Success Rate, where at PHC 86.1%, DOTS hospital 77.78% and Non DOTS hospital 63.89%. The addition cost providers especially person in charge at PHC and DOTS hospital increase success rate. The cost of TB treatment in PHC 42% of private hospital. ACER (Average Cost Effectiveness Ratio) is obtained that the hospital which carry out the DOTS strategy is cost effective. To increase 1% success rate of TB treatment costs Rp 10,084,572 with intervention DOTS programs into a private hospital. An Independent t test stated that cost-effectiveness societal perspectives on TB treatment has a significant difference between PHC, DOTS hospital and Non DOTS hospital.



Keywords


ACER; Cost effectiveness analysis; DOTS; ICER; Private hospital; Success Rate

References


(1) Achmad, Asnawi. 2009. Gambaran Persepsi Pasien terhadap Pelayanan Kesehatan di Puskesmas Sukmajaya Kota Depok Tahun 2009. University of Indonesia. [Accessed: 24 April 2018]. Available at: http://lib.ui.ac.id/file?file=digital/125471-S- 5706-Gambaran persepsi-Abstrak.pdf.

(2) Amrita Parida et al.. 2014. Comparison of Directly Observed Treatment Short Course (DOTS) with Self- Administered Therapy in Pulmonary Tuberculosis in Udupi District of Southern India. Journal of Clinical and Diagnostic Research. 8(8): 29–31.

(3) Dianasari, I., Mubasyiroh, R. and Supardi, S. 2017. Hubungan Pengetahuan dan Sikap dengan Kepatuhan Berobat pada Pasien TB Paru yang Rawat Jalan di Jakarta Tahun 2014. Media Penelitian dan Pengembangan Kesehatan. 26(4): 243–248.

(4) Getahun, B. and Nkosi, Z. Z. 2017.‘Is directly observed tuberculosis treatment strategy patient-centered? A mixed method study in Addis Ababa, Ethiopia. PLOS ONE. Edited by M. Pai. Public Library of Science.12(8): 181-205

(5) Johns, B. et al. 2009. An analysis of the costs and treatment success of collaborative arrangements among public and private providers for tuberculosis control in Indonesia. Health Policy. 93(2–3): 214–224.

(6) Katherine Floyd, VK Arora, KJR Murthy, Knut Lönnroth, Neeta Singla, Y Akbar, Matteo Zignol, & M. U. 2011. Cost and cost-effectiveness of PPM-DOTS for tuberculosis control: evidence from India. Bulletin of WHO. World Health Organization, 84 Number 6(June 2006), pp. 425–504. 1 June 2017. .

(7) Laurence, Y. V, Griffiths, U. K. and Vassall, A. 2015. Costs to Health Services and the Patient of Treating Tuberculosis: A Systematic Literature Review. PharmacoEconomics. Springer, 33(9): 939–55.

(8) Lemeshow, S. et al. 1990. adequacy of Sample Size in Health Studies. West Sussex: John Wiley & Sons Ltd. 30 September 2017. .

(9) Mantala, M. J. et al. 2003. Public–private mix DOTS in the Philippines, Tuberculosis. BioMed Central,. 83(1–3): 173–176.

(10) Pantoja, A. et al. 2006. Economic evaluation of public-private mix for tuberculosis care and control, India. Part II. Cost and cost-effectiveness. The International Journal of Tuberculosis and Lung Disease. International Union Against Tuberculosis and Lung Disease. 13 (6): 705–712.

(11) Putri, G. F. and Hisyam. 2014. Hubungan Tingkat Kesembuhan Tuberkulosis Paru Dewasa Dengan Pengobatan Metode DOTS dan Non DOTS di Rumah Sakit Haji Abdoel Madjid Batoe Kabupaten Batanghari Provinsi Jambi Tahun 2011. JKKI. 6(2): 85–94.

(12) Ramaiah, A. A. and Gawde, N. C. 2015a. Economic Evaluation of a Public–Private Mix TB Project in Tamil Nadu, India. Journal of Health Management. SAGE Publications Sage India: New Delhi, India, 17(3): 370–380.

(13) Reviono, R. et al. 2017. The dynamic of tuberculosis case finding in the era of the public–private mix strategy for tuberculosis control in Central Java, Indonesia. Global Health Action. Taylor & Francis, 10(1): 1353777.

(14) Sinanovic, E. and Kumaranayake, L. 2006. Financing and cost-effectiveness analysis of public-private partnerships: provision of tuberculosis treatment in South Africa. Cost Effectiveness and Resource Allocation. 4(1): 11.

(15) Steffen, R. et al. 2010. Patients’ costs and cost-effectiveness of tuberculosis treatment in DOTS and non-DOTS facilities in Rio de Janeiro, Brazil.’ PloS one. Public Library of Science. 5(11): e14014.

(16) Suhariadi, F. et al. 2016. The tale of seeking treatment: A qualitative study of pulmonary tuberculosis patients. Psychology, Community & Health, 5(3): 229–243.

(17) Tarigan, I. and Suryati, T. 2017. Gambaran Out of Pocket pada Awal Era JKN di Indonesia. Ejournal. Litbang.Depkes.Go.Id. 1(2): 141–146.

(18) WHO. 2016. Global Tuberculosis Report 2016. 3 June 2017. .

(19) WHO. 2017. Public-Private Mix for TB Care and Control - A toolkit. 1 June 2017. .

(20) Mahendradhata, Y. et al. 2010. The Incremental Cost-Effectiveness of Engaging Private Practitioners to Refer Tuberculosis Suspects to DOTS Services in Jogjakarta, Indonesia. Am. J. Trop. Med. Hyg. 82(6): 1131–1139.


Full Text: PDF

DOI: 10.7454/eki.v3i1.2321

Refbacks

  • There are currently no refbacks.